The long-term goal of research in the Hadden lab is to utilize a medicinal chemistry/chemical biology approach to understand the mechanisms through which dysregulation of cellular signaling pathways contributes to the onset of human cancer and to apply this knowledge to develop improved therapeutics that target these pathways. To this end, we use a combination of organic synthesis and molecular biology techniques to prepare and evaluate small molecule modulators of these therapeutic targets. Major ongoing projects include the development of hedgehog pathway modulators as therapeutic agents and the development of small molecule inhibitors of translesion synthesis.

We are always interested in hearing from potential graduate students or postdoctoral researchers, especially those who have their own funding. Please contact Professor Hadden if you are interested in our research or want to discuss the possibility of open positions.

Phone:	860-486-8446
E-mail:	kyle.hadden@uconn.edu
Address:	69 N Eagleville Rd Unit 3092 Storrs, CT 06269 Pharmacy & Biology Building Office - PBB 628 Labs - PBB 510, 512, and 516